vs
Blend Labs, Inc.（BLND）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Blend Labs, Inc.的1.1倍（$35.5M vs $32.4M），Blend Labs, Inc.净利率更高（-7.8% vs -304.2%，领先296.4%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 7.6%），Blend Labs, Inc.自由现金流更多（$-21.0K vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 16.6%）
GU Energy Labs是一家总部位于美国加利福尼亚州伯克利的运动营养产品生产商，核心产品为深受耐力运动爱好者青睐的能量胶，可在各类运动中快速易消化吸收。此外品牌还推出能量咀嚼糖、冲调饮品、补水片、 stroopwafel荷蘭焦糖煎餅以及Roctane系列产品，涵盖能量冲饮、蛋白恢复冲饮、能量胶和胶囊等，公司于1994年由比尔·沃恩创立。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
BLND vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $32.4M | $35.5M |
| 净利润 | $-2.5M | $-108.1M |
| 毛利率 | 75.7% | 59.8% |
| 营业利润率 | -11.1% | -304.8% |
| 净利率 | -7.8% | -304.2% |
| 营收同比 | 7.6% | 681.7% |
| 净利润同比 | -207.0% | 39.6% |
| 每股收益（稀释后） | — | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $32.4M | $35.5M | ||
| Q3 25 | $32.7M | $5.2M | ||
| Q2 25 | $31.6M | $19.2M | ||
| Q1 25 | $26.8M | $14.7M | ||
| Q4 24 | $30.1M | $4.5M | ||
| Q3 24 | $33.1M | $26.1M | ||
| Q2 24 | $28.7M | $14.4M | ||
| Q1 24 | $23.8M | $13.8M |
| Q4 25 | $-2.5M | $-108.1M | ||
| Q3 25 | $12.1M | $-162.3M | ||
| Q2 25 | $-6.8M | $-171.9M | ||
| Q1 25 | $-9.5M | $-202.5M | ||
| Q4 24 | $-825.0K | $-178.9M | ||
| Q3 24 | $-2.4M | $-95.8M | ||
| Q2 24 | $-19.4M | $-97.5M | ||
| Q1 24 | $-20.7M | $-91.4M |
| Q4 25 | 75.7% | 59.8% | ||
| Q3 25 | 74.3% | -183.8% | ||
| Q2 25 | 73.8% | -4.9% | ||
| Q1 25 | 70.8% | -48.0% | ||
| Q4 24 | 74.2% | -181.4% | ||
| Q3 24 | 74.0% | 53.7% | ||
| Q2 24 | 70.9% | 36.2% | ||
| Q1 24 | 67.3% | 19.1% |
| Q4 25 | -11.1% | -304.8% | ||
| Q3 25 | -16.4% | -3327.6% | ||
| Q2 25 | -15.3% | -916.8% | ||
| Q1 25 | -29.7% | -1297.9% | ||
| Q4 24 | -10.9% | -4042.4% | ||
| Q3 24 | -34.1% | -377.1% | ||
| Q2 24 | -45.5% | -697.4% | ||
| Q1 24 | -89.0% | -698.4% |
| Q4 25 | -7.8% | -304.2% | ||
| Q3 25 | 37.0% | -3135.3% | ||
| Q2 25 | -21.6% | -894.2% | ||
| Q1 25 | -35.5% | -1373.3% | ||
| Q4 24 | -2.7% | -3935.5% | ||
| Q3 24 | -7.4% | -367.5% | ||
| Q2 24 | -67.6% | -676.6% | ||
| Q1 24 | -86.7% | -662.4% |
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $0.02 | $-0.36 | ||
| Q2 25 | — | $-0.41 | ||
| Q1 25 | — | $-0.50 | ||
| Q4 24 | $-0.03 | $-0.56 | ||
| Q3 24 | $-0.03 | $-0.34 | ||
| Q2 24 | $-0.09 | $-0.40 | ||
| Q1 24 | $-0.09 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $68.3M | $743.3M |
| 总债务越低越好 | $0 | $9.6M |
| 股东权益账面价值 | $-30.5M | $1.1B |
| 总资产 | $170.0M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $68.3M | $743.3M | ||
| Q3 25 | $77.3M | $659.8M | ||
| Q2 25 | $88.3M | $525.1M | ||
| Q1 25 | $104.8M | $500.5M | ||
| Q4 24 | $94.2M | $594.4M | ||
| Q3 24 | $112.3M | $427.6M | ||
| Q2 24 | $108.9M | $474.3M | ||
| Q1 24 | $121.1M | $296.3M |
| Q4 25 | $0 | $9.6M | ||
| Q3 25 | $0 | $11.9M | ||
| Q2 25 | $0 | $14.2M | ||
| Q1 25 | $0 | $16.4M | ||
| Q4 24 | $0 | $19.0M | ||
| Q3 24 | $0 | $20.5M | ||
| Q2 24 | $0 | $22.9M | ||
| Q1 24 | $138.9M | — |
| Q4 25 | $-30.5M | $1.1B | ||
| Q3 25 | $-13.4M | $1.0B | ||
| Q2 25 | $-23.1M | $919.1M | ||
| Q1 25 | $-17.2M | $933.9M | ||
| Q4 24 | $-56.4M | $1.0B | ||
| Q3 24 | $-49.6M | $524.6M | ||
| Q2 24 | $-45.5M | $584.4M | ||
| Q1 24 | $-35.8M | $401.2M |
| Q4 25 | $170.0M | $1.5B | ||
| Q3 25 | $188.6M | $1.4B | ||
| Q2 25 | $182.2M | $1.3B | ||
| Q1 25 | $187.5M | $1.3B | ||
| Q4 24 | $178.1M | $1.4B | ||
| Q3 24 | $186.1M | $726.5M | ||
| Q2 24 | $185.4M | $775.9M | ||
| Q1 24 | $201.8M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.5M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-21.0K | $-47.3M |
| 自由现金流率自由现金流/营收 | -0.1% | -133.1% |
| 资本支出强度资本支出/营收 | 4.8% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-81.0K | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $1.5M | $-46.1M | ||
| Q3 25 | $-3.6M | $-117.4M | ||
| Q2 25 | $-6.5M | $-76.4M | ||
| Q1 25 | $20.1M | $-132.0M | ||
| Q4 24 | $-4.6M | $-115.4M | ||
| Q3 24 | $2.1M | $-59.2M | ||
| Q2 24 | $-6.7M | $-82.2M | ||
| Q1 24 | $-3.9M | $-102.3M |
| Q4 25 | $-21.0K | $-47.3M | ||
| Q3 25 | $-5.8M | $-117.6M | ||
| Q2 25 | $-10.1M | $-79.6M | ||
| Q1 25 | $15.8M | $-133.8M | ||
| Q4 24 | $-7.1M | $-116.7M | ||
| Q3 24 | $-1.4M | $-63.8M | ||
| Q2 24 | $-8.5M | $-83.4M | ||
| Q1 24 | $-5.8M | $-109.0M |
| Q4 25 | -0.1% | -133.1% | ||
| Q3 25 | -17.6% | -2272.5% | ||
| Q2 25 | -31.9% | -413.9% | ||
| Q1 25 | 58.9% | -907.4% | ||
| Q4 24 | -23.5% | -2567.7% | ||
| Q3 24 | -4.1% | -244.6% | ||
| Q2 24 | -29.7% | -578.5% | ||
| Q1 24 | -24.5% | -789.9% |
| Q4 25 | 4.8% | 3.5% | ||
| Q3 25 | 6.5% | 4.7% | ||
| Q2 25 | 11.4% | 16.4% | ||
| Q1 25 | 16.1% | 12.4% | ||
| Q4 24 | 8.3% | 28.6% | ||
| Q3 24 | 10.4% | 17.5% | ||
| Q2 24 | 6.5% | 8.2% | ||
| Q1 24 | 8.2% | 48.2% |
| Q4 25 | — | — | ||
| Q3 25 | -0.30× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLND
| Mortgage Suite | $18.9M | 58% |
| Consumer Banking Suite | $11.4M | 35% |
| Professional Services | $2.1M | 6% |
RXRX
暂无分部数据
